Everest Medicines Ltd. is a biopharmaceutical company, which engages in the discovering, developing, manufacturing, and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asian markets. The company is headquartered in Shanghai, Shanghai and currently employs 722 full-time employees. The company went IPO on 2020-10-09. The firm has built a product pipeline across renal, anti-infective, and autoimmune diseases. The Company’s products portfolio includes Nefecon (TARPEYO) using in the renal therapeutic area, XERAVA (eravacycline) using in the treatment of infections caused by susceptible gram-positive, gram-negative and anaerobic pathogens including those multidrug resistant isolates and other products. The firm conducts its business in the domestic and overseas markets.
01952.HK stock price ended at $38.24 on Perşembe, after dropping 2.85%
On the latest trading day Feb 12, 2026, the stock price of 01952.HK fell by 2.85%, dropping from $39.36 to $38.24. During the session, the stock saw a volatility of 4.03%, with prices oscillating between a daily low of $38.22 and a high of $39.76. On the latest trading day, the trading volume for 01952.HK rose by 37.1K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 1.5M shares were traded, with a market value of approximately $13.5B.
01952.HKTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 2
Nötr Sinyaller 2
Satış Sinyalleri 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
01952.HK, şu anda 2 alım sinyali ve 3 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Aşağı yönlü trend durumundadır ve bu dönemde toplam -3.14% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Sell görünüm işaret etmektedir.
01952.HK için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek 01952.HK için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.